On 25 February 2026, Federal Finance Minister Lars Klingbeil presented the German government’s action plan against organised crime. The key sentence, documented on the press release of his own Federal Ministry of Finance:
On 28 April 2026, Berlin’s senator for science, health and care, Ina Czyborra (SPD), issued a press release titled “Senate weighs options to improve HPV vaccination coverage”. Core sentence: “HPV can cause cancer — and we have it in our hands to protect ourselves effectively against it.” The plan: information letters to parents of pupils in grades 4 through 10, integrating vaccination into the new U10 child-health check-up, and reminder systems where check-ups are missed.
On 24 April 2026, in the early afternoon, Germany’s Paul-Ehrlich-Institut (PEI) — the federal agency for vaccines and biomedical medicines — posts from its official X account @PEI_Germany a card marking the end of European Immunisation Week. On the card: a cartoon family — mother, child, teenager, adult, elderly woman, male nurse in headscarf. Above it, in friendly green, with an exclamation mark:
The vaccination rate among over-60s for the flu shot is, according to the RKI, at its lowest level in 17 years [1]. The COVID-19 vaccination rate in this age group has fallen by more than a third compared to the previous season [2]. At the same time, data from Denmark show that different BioNTech batches showed different adverse-event rates — a study that the PEI dismissed as “not meaningful” without presenting its own data [3].
No monitoring, no data, no consequences — but the vaccines were of course “safe and effective.”
It is one of the biggest scandals in Germany’s postwar history — and hardly anyone is talking about it. BioNTech, the Mainz-based company celebrated as the hero of the pandemic, positioned itself legally so that it is formally not even a vaccine manufacturer. And the authority responsible for monitoring vaccine safety — the Paul Ehrlich Institute (PEI) — failed to evaluate the legally mandated data for years.
